← All stocks

Kyverna Therapeutics, Inc.

KYTX No buying or selling

CIK 0001994702 #3077 in the set updated 19 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

14 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

SEIDENBERG BETH C

Director

—

891,044

$6.68M

+21.1%

Westlake BioPartners Opportunity Fund I, L.P. entity

10% owner

—

869,317

$6.52M

+18.1%

Shaw Christi

Executive Chairperson

—

66,741

$500.56K

—

Biddle Warner Weston

Chief Executive Officer

—

58,000

$435.00K

—

Jones Ryan Alexander

Chief Financial Officer

—

55,950

$419.63K

+27.3%

Walker Karen Marie

Chief Technology Officer

—

22,636

$169.77K

+134.9%

CLARK IAN T

Director

—

21,727

$162.95K

—

Cohen Fred E

Director

—

21,727

$162.95K

—

Aktar Mert

Director

—

21,727

$162.95K

—

GEHCHAN NAJI

See Remarks

—

18,000

$135.00K

—

SPIEGELMAN DANIEL K

Director

—

16,634

$124.76K

—

Emany Sravan Kumar

Director

—

11,006

$82.55K

—

Miller Andrew Craig

Director

—

11,006

$82.55K

—

GRASSO MARC

Chief Financial Officer

—

10,000

$75.00K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 12 Feb 2024